DIA
Drug Information Association Logo

Examination of the Adoption of FDA's Bio-pharmaceutics Classification System (BCS): A Qualitative Study

Time

Mon, Jun 25 11:00AM
M 09

Title

Examination of the Adoption of FDA's Bio-pharmaceutics Classification System (BCS): A Qualitative Study

Abstract Summary

Telephone interviews with 20 individuals from brand and generic companies, government, and academia were conducted. Interviewees were selected based on literature review, list of sponsor contacts, etc. Respondents were asked to describe their interest, experience and utilization of BCS.

Poster Presenter

Namita Joshi
MSc,
Graduate research Assistant and Doctoral Student,
University of Mississippi
United States

© 2015 DIA